Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Kobayashi Pharmaceutical: analyst estimates show quarterly profit decline, moderate revenue growth
Kobayashi Pharmaceutical will release quarterly results for the quarter ended March 31, 2026, on May 8, 2026; one analyst expects earnings per share of JPY 5.38 versus JPY 21.86 in the year-ago quarter. Five analysts estimate quarterly revenue at an average of JPY 33.74 billion, up 3.46% from JPY 32.61 billion a year earlier. For the fiscal year, eight analysts on average forecast EPS of JPY 151.58 (prior year JPY 49.19) and revenue of JPY 173.49 billion versus JPY 165.74 billion in the prior year. » More on finanzen.net
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 199.78m | 7.00% |
| Gross profit | 99.78m | 13.09% |
| Net profit | 544.12k | 94.02% |
| EBITDA | 17.88m | 34.68% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €3.02bn |
Number of shares | 74.34m |
52-week high/low | €42.04 - €28.63 |
Dividend yield | 1.42% |
Dividends TTM | €0.58 |
Beta | 0.27 |
P/E ratio | 325.93 |
PEG ratio | -3.78 |
P/B ratio | 2.53 |
P/S ratio | 3.16 |
Company profile
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, skincare, body warmer, and household. It also offers Ammeltz, a topical analgesic; Inochi no Haha, a women's health medicine; Shirt Coola, a summer cooling spray for cloths; Sarasaty lingerie soap; Bluelet Decoral, a toilet bowl cleaner and freshener; Nightmin Nasal Respiration Tape; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; Itoyoji, a dental floss pick; BreathCare, an oral breath freshener capsule; Eybon, an eye wash; Netsusama sheet, a cooling gel sheet for forehead; and Sawaday, a toilet air freshener. Additionally, the company manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products; markets nutritional supplements and skin care products through sales promotional campaigns, such as advertising and direct mail; and sells skincare products, health foods, and other items through e-commerce channels. Further, it engages in transportation, real estate management, and advertising planning and production businesses. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
| Name | Kobayashi Pharmaceut. |
| CEO | Norikazu Toyoda |
| Headquarters | Osaka,
os Japan |
| Website | |
| IPO | 04/01/2001 |
| Employees | 3,731 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Japan Exchange Group | 4967.T |
Frankfurt | KOY.F |
Düsseldorf | KOY.DU |
München | KOY.MU |